Загрузка...
Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
Parthenolide is a natural product that exhibits anti-leukaemic activity, however, its clinical use is limited by its poor bioavailability. It may be extracted from feverfew and protocols for growing, extracting and derivatising it are reported. A novel parthenolide derivative with good bioavailabili...
Сохранить в:
| Опубликовано в: : | Medchemcomm |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal Society of Chemistry
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7478165/ https://ncbi.nlm.nih.gov/pubmed/32952998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9md00297a |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|